| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$24,511,741 |
|
|
|
Indirect Value
|
$3,299,393 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2009-05-18 |
4 |
AS |
$28.44 |
$22,269 |
D/D |
(783) |
40,366 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-01-08 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
41,190 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-02-17 |
4 |
D |
$241.50 |
$787,773 |
D/D |
(3,262) |
42,936 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-05 |
4 |
OE |
$77.31 |
$367,327 |
D/D |
4,520 |
43,683 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$640,961 |
D/D |
(2,946) |
43,719 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-04-27 |
4 |
OE |
$86.52 |
$336,044 |
D/D |
3,884 |
44,017 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
44,126 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
• – – |
2011-02-23 |
4 |
AS |
$43.60 |
$1,043,666 |
D/D |
(23,828) |
44,126 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
• – – |
2010-10-26 |
4 |
AS |
$37.50 |
$170,025 |
D/D |
(4,534) |
44,910 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-23 |
4 |
OE |
$86.52 |
$503,892 |
D/D |
5,824 |
44,987 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-11 |
4 |
OE |
$131.89 |
$1,406,607 |
D/D |
10,665 |
45,768 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-02-11 |
4 |
AS |
$243.53 |
$3,216,311 |
D/D |
(13,070) |
46,198 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-12 |
4 |
AS |
$149.22 |
$2,684,411 |
D/D |
(17,796) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-26 |
4 |
AS |
$170.00 |
$366,350 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-03-09 |
4 |
AS |
$175.00 |
$2,406,250 |
D/D |
(13,750) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$12,930 |
D/D |
(83) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-06-29 |
4 |
AS |
$165.00 |
$686,615 |
D/D |
(4,096) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-13 |
4 |
AS |
$180.00 |
$2,165,580 |
D/D |
(12,031) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-16 |
4 |
AS |
$180.14 |
$310,042 |
D/D |
(1,719) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-02 |
4 |
AS |
$175.06 |
$380,852 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-03 |
4 |
AS |
$174.50 |
$340,050 |
D/D |
(1,942) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-02 |
4 |
AS |
$171.93 |
$372,505 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-05 |
4 |
AS |
$172.70 |
$337,204 |
D/D |
(1,941) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-15 |
4 |
AS |
$163.75 |
$9,989 |
D/D |
(61) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-18 |
4 |
AS |
$210.00 |
$1,962,366 |
D/D |
(9,264) |
46,665 |
0 |
% |
|
193 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
